ALMKT.PA Mauna Kea Technologies SAS

Healthcare Health Care Equipment & Supplies Euronext Paris
0.0910 EUR
Close of Nov 8, 2026
0.0692 0.2315
Market cap
EUR 18.1M
P/E
0.6x
P/B
128.61x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is ALMKT.PA undervalued?

Graham number
Price0.0910
Graham value0.0505
Premium80.3%

ALMKT.PA trades 80.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Mauna Kea Technologies SAS fundamental analysis

No fundamental analysis for Mauna Kea Technologies SAS yet.

Mauna Kea Technologies SAS stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Mauna Kea Technologies SAS

Mauna Kea Technologies SA manufactures and sells medical devices in Europe, Middle East, Africa, the United States, Canada, and Asia. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables physicians to monitor disease progression over time, assess reactions as they occur, classify areas of uncertainty, and guide surgical procedures,…

Full company profile